Suppr超能文献

阻断盐诱导激酶 1 网络可预防由人类 α-辅肌动蛋白中与高血压相关的突变引起的细胞钠转运增加。

Blocking the salt-inducible kinase 1 network prevents the increases in cell sodium transport caused by a hypertension-linked mutation in human alpha-adducin.

机构信息

Membrane Signaling Networks, Atherosclerosis Research Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital-Solna, Stockholm, Sweden.

出版信息

J Hypertens. 2009 Dec;27(12):2452-7. doi: 10.1097/HJH.0b013e328330cf15.

Abstract

OBJECTIVES

Because a newly described salt-inducible kinase 1 (SIK1) network is responsible for increases in active cell sodium transport in response to elevated intracellular sodium, we hypothesized that this network could mediate the effects of the mutant (hypertensive) form of alpha-adducin on Na,K-ATPase activity.

METHODS

Studies were performed in normotensive and hypertensive Milan rats and in a cell line of proximal tubule origin expressing transiently variants of alpha-adducin (human G460W/S586C; rat F316Y) that are associated with elevated blood pressure and result in increased Na,K-ATPase activity. Na,K-ATPase activity was determined as ouabain-sensitive rubidium transport.

RESULTS

SIK1 activity (T182 phosphorylation) was significantly elevated in renal proximal tubule cells from Milan hypertensive rats (carrying a alpha-adducin mutation) when compared with normotensive controls. Similarly, SIK1 activity (T182 phosphorylation) was elevated in a normal renal proximal tubule cell line when transfected with the alpha-adducin variant carrying the human hypertensive mutation. Blocking the SIK1 network using negative mutants as well as different stages of its activation pathway prevented the effects induced by the hypertensive alpha-adducin.

CONCLUSION

The SIK1 network may constitute an alternative target by which agents can modulate active sodium transport in renal epithelia and avoid the increases in systemic blood pressure that are associated with genetic mutations in the human alpha-adducin molecule.

摘要

目的

由于新描述的盐诱导激酶 1(SIK1)网络负责增加细胞内钠水平升高时的活性细胞钠转运,我们假设该网络可以介导突变(高血压)形式的α辅肌动蛋白对 Na,K-ATP 酶活性的影响。

方法

在正常血压和高血压米兰大鼠以及表达瞬时变体α辅肌动蛋白(人 G460W/S586C;大鼠 F316Y)的近端肾小管细胞系中进行了研究,这些变体与血压升高有关,并导致 Na,K-ATP 酶活性增加。Na,K-ATP 酶活性通过哇巴因敏感的铷转运来确定。

结果

与正常血压对照组相比,来自米兰高血压大鼠(携带α辅肌动蛋白突变)的肾近端小管细胞中 SIK1 活性(T182 磷酸化)显着升高。同样,当用携带人类高血压突变的α辅肌动蛋白变体转染正常肾近端小管细胞系时,SIK1 活性(T182 磷酸化)升高。使用负突变体以及其激活途径的不同阶段阻断 SIK1 网络可防止由高血压α辅肌动蛋白引起的作用。

结论

SIK1 网络可能构成替代靶标,通过该靶标可以调节肾上皮细胞中的活性钠转运,并避免与人类α辅肌动蛋白分子中的遗传突变相关的全身血压升高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验